Histiocytic disorders: insights into novel biology and implications for therapy of Langerhans cell histiocytosis and Erdheim-Chester disease
Open Access
- 4 December 2020
- journal article
- research article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2020 (1) , 395-399
Abstract
Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) are caused by mutations of the MAPK pathway, most often BRAFV600E, in myeloid dendritic cells that lead to some overlapping and other unique presentations of the two diseases. LCH occurs in both children and adults, but ECD is primarily found in the latter. The challenges in diagnosing these conditions relates to the rarity of the conditions and that they mimic diseases that are more widely understood, such as certain rashes; bone, lung, and renal diseases; and other malignancies. The histopathology of LCH is definitive, but not so for ECD. Treatment with BRAF and MEK inhibitors has become one of the important advances in the care of these patients.Keywords
This publication has 42 references indexed in Scilit:
- Optimal Therapy for Adults with Langerhans Cell Histiocytosis Bone LesionsPLOS ONE, 2012
- CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patientsBlood, 2011
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans CellsThe Journal of Immunology, 2010
- Erdheim-Chester disease: report on a case and new insights on its immunopathogenesisRheumatology, 2010
- 18F‐fluorodeoxyglucose–positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim‐Chester diseaseArthritis & Rheumatism, 2009
- Comparison of FDG‐PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosisPediatric Blood & Cancer, 2008
- A phase II trial using thalidomide for Langerhans cell histiocytosisPediatric Blood & Cancer, 2005
- Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literatureJournal of Clinical Pathology, 2004
- Über LipoidgranulomatoseVirchows Archiv, 1930